Q32 Bio Inc (NASDAQ:QTTB) shares, rose in value on Wednesday, June 18, with the stock price down by -1.54% to the previous day’s close as strong demand from buyers drove the stock to $1.60.
Actively observing the price movement in the last trading, the stock closed the session at $1.62, falling within a range of $1.58 and $1.64. Referring to stock’s 52-week performance, its high was $53.79, and the low was $1.38. On the whole, QTTB has fluctuated by -8.33% over the past month.
With the market capitalization of Q32 Bio Inc currently standing at about $19.46 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that QTTB’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of QTTB currently trading nearly -8.71% and -8.52% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.17, while the 7-day volatility ratio is showing 1.73% which for the 30-day chart, stands at 4.62%. Furthermore, Q32 Bio Inc (QTTB)’s beta value is -0.03, and its average true range (ATR) is 0.14.
A comparison of Q32 Bio Inc (QTTB) with its peers suggests the former has fared considerably weaker in the market. QTTB showed an intraday change of -1.54% in last session, and over the past year, it shrunk by -91.43%%.
Data on historical trading for Q32 Bio Inc (NASDAQ:QTTB) indicates that the trading volumes over the past 10 days have averaged 95800.0 and over the past 3 months, they’ve averaged 153.37K. According to company’s latest data on outstanding shares, there are 12.20 million shares outstanding.
Nearly 63.56% of Q32 Bio Inc’s shares belong to company insiders and institutional investors own 19.22% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.46 million shares as on 2025-05-30, resulting in a short ratio of 3.11. According to the data, the short interest in Q32 Bio Inc (QTTB) stood at 1339.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.55 million. The stock has fallen by -53.63% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the QTTB stock heading into the next quarter.
